nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2D6—Carteolol—glaucoma	0.0637	0.123	CbGbCtD
Irbesartan—CYP1A2—Betaxolol—glaucoma	0.0522	0.101	CbGbCtD
Irbesartan—CYP2D6—Betaxolol—glaucoma	0.043	0.0829	CbGbCtD
Irbesartan—CYP2C9—Diclofenamide—glaucoma	0.0414	0.0798	CbGbCtD
Irbesartan—CYP2C9—Dorzolamide—glaucoma	0.04	0.0771	CbGbCtD
Irbesartan—CYP2C9—Methazolamide—glaucoma	0.0357	0.0687	CbGbCtD
Irbesartan—CYP2D6—Methazolamide—glaucoma	0.0326	0.0628	CbGbCtD
Irbesartan—CYP3A4—Pilocarpine—glaucoma	0.0307	0.0592	CbGbCtD
Irbesartan—CYP1A2—Clonidine—glaucoma	0.0286	0.0551	CbGbCtD
Irbesartan—CYP2D6—Timolol—glaucoma	0.0277	0.0534	CbGbCtD
Irbesartan—CYP3A4—Brinzolamide—glaucoma	0.0241	0.0464	CbGbCtD
Irbesartan—CYP2D6—Clonidine—glaucoma	0.0236	0.0454	CbGbCtD
Irbesartan—CYP3A4—Dorzolamide—glaucoma	0.0233	0.0448	CbGbCtD
Irbesartan—CYP3A4—Methazolamide—glaucoma	0.0207	0.04	CbGbCtD
Irbesartan—CYP3A4—Acetazolamide—glaucoma	0.0166	0.0319	CbGbCtD
Irbesartan—CYP3A4—Clonidine—glaucoma	0.015	0.0289	CbGbCtD
Irbesartan—Diarrhoea—Apraclonidine—glaucoma	0.000187	0.00058	CcSEcCtD
Irbesartan—Malaise—Clonidine—glaucoma	0.000187	0.00058	CcSEcCtD
Irbesartan—Mediastinal disorder—Betaxolol—glaucoma	0.000187	0.000579	CcSEcCtD
Irbesartan—Dyspepsia—Pilocarpine—glaucoma	0.000186	0.000578	CcSEcCtD
Irbesartan—Chills—Betaxolol—glaucoma	0.000186	0.000577	CcSEcCtD
Irbesartan—Syncope—Clonidine—glaucoma	0.000186	0.000576	CcSEcCtD
Irbesartan—Arrhythmia—Betaxolol—glaucoma	0.000185	0.000574	CcSEcCtD
Irbesartan—Feeling abnormal—Dorzolamide—glaucoma	0.000185	0.000573	CcSEcCtD
Irbesartan—Decreased appetite—Pilocarpine—glaucoma	0.000184	0.000571	CcSEcCtD
Irbesartan—Feeling abnormal—Travoprost—glaucoma	0.000184	0.00057	CcSEcCtD
Irbesartan—Conjunctivitis—Timolol—glaucoma	0.000183	0.000569	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000183	0.000568	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000183	0.000567	CcSEcCtD
Irbesartan—Gastrointestinal pain—Travoprost—glaucoma	0.000182	0.000566	CcSEcCtD
Irbesartan—Loss of consciousness—Clonidine—glaucoma	0.000182	0.000565	CcSEcCtD
Irbesartan—Feeling abnormal—Brinzolamide—glaucoma	0.000181	0.000563	CcSEcCtD
Irbesartan—Pain—Pilocarpine—glaucoma	0.000181	0.000562	CcSEcCtD
Irbesartan—Constipation—Pilocarpine—glaucoma	0.000181	0.000562	CcSEcCtD
Irbesartan—Cough—Clonidine—glaucoma	0.000181	0.000561	CcSEcCtD
Irbesartan—Dizziness—Apraclonidine—glaucoma	0.000181	0.000561	CcSEcCtD
Irbesartan—Malnutrition—Betaxolol—glaucoma	0.00018	0.00056	CcSEcCtD
Irbesartan—Erythema—Betaxolol—glaucoma	0.00018	0.00056	CcSEcCtD
Irbesartan—Urticaria—Dorzolamide—glaucoma	0.000178	0.000552	CcSEcCtD
Irbesartan—Epistaxis—Timolol—glaucoma	0.000178	0.000552	CcSEcCtD
Irbesartan—Abdominal pain—Dorzolamide—glaucoma	0.000177	0.00055	CcSEcCtD
Irbesartan—Body temperature increased—Dorzolamide—glaucoma	0.000177	0.00055	CcSEcCtD
Irbesartan—Tension—Betaxolol—glaucoma	0.000177	0.000549	CcSEcCtD
Irbesartan—Dysgeusia—Betaxolol—glaucoma	0.000177	0.000548	CcSEcCtD
Irbesartan—Chest pain—Clonidine—glaucoma	0.000176	0.000547	CcSEcCtD
Irbesartan—Arthralgia—Clonidine—glaucoma	0.000176	0.000547	CcSEcCtD
Irbesartan—Abdominal pain—Travoprost—glaucoma	0.000176	0.000547	CcSEcCtD
Irbesartan—Agranulocytosis—Timolol—glaucoma	0.000176	0.000546	CcSEcCtD
Irbesartan—Anxiety—Clonidine—glaucoma	0.000176	0.000545	CcSEcCtD
Irbesartan—Asthenia—Acetazolamide—glaucoma	0.000175	0.000544	CcSEcCtD
Irbesartan—Dizziness—Bimatoprost—glaucoma	0.000175	0.000544	CcSEcCtD
Irbesartan—Nervousness—Betaxolol—glaucoma	0.000175	0.000544	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000175	0.000543	CcSEcCtD
Irbesartan—Urticaria—Brinzolamide—glaucoma	0.000175	0.000543	CcSEcCtD
Irbesartan—Feeling abnormal—Pilocarpine—glaucoma	0.000174	0.000541	CcSEcCtD
Irbesartan—Discomfort—Clonidine—glaucoma	0.000174	0.000541	CcSEcCtD
Irbesartan—Vomiting—Apraclonidine—glaucoma	0.000174	0.000539	CcSEcCtD
Irbesartan—Muscle spasms—Betaxolol—glaucoma	0.000173	0.000538	CcSEcCtD
Irbesartan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000173	0.000537	CcSEcCtD
Irbesartan—Hypersensitivity—Brimonidine—glaucoma	0.000173	0.000536	CcSEcCtD
Irbesartan—Dry mouth—Clonidine—glaucoma	0.000172	0.000535	CcSEcCtD
Irbesartan—Bradycardia—Timolol—glaucoma	0.000172	0.000535	CcSEcCtD
Irbesartan—Dermatitis—Apraclonidine—glaucoma	0.000172	0.000534	CcSEcCtD
Irbesartan—Headache—Apraclonidine—glaucoma	0.000171	0.000531	CcSEcCtD
Irbesartan—Vision blurred—Betaxolol—glaucoma	0.00017	0.000527	CcSEcCtD
Irbesartan—Rhinitis—Timolol—glaucoma	0.00017	0.000526	CcSEcCtD
Irbesartan—Oedema—Clonidine—glaucoma	0.000169	0.000525	CcSEcCtD
Irbesartan—Tremor—Betaxolol—glaucoma	0.000169	0.000524	CcSEcCtD
Irbesartan—Asthenia—Brimonidine—glaucoma	0.000168	0.000522	CcSEcCtD
Irbesartan—Infection—Clonidine—glaucoma	0.000168	0.000521	CcSEcCtD
Irbesartan—Abdominal pain—Pilocarpine—glaucoma	0.000167	0.000519	CcSEcCtD
Irbesartan—Body temperature increased—Pilocarpine—glaucoma	0.000167	0.000519	CcSEcCtD
Irbesartan—Ill-defined disorder—Betaxolol—glaucoma	0.000167	0.000519	CcSEcCtD
Irbesartan—Diarrhoea—Acetazolamide—glaucoma	0.000167	0.000519	CcSEcCtD
Irbesartan—Rash—Bimatoprost—glaucoma	0.000167	0.000518	CcSEcCtD
Irbesartan—Dermatitis—Bimatoprost—glaucoma	0.000167	0.000518	CcSEcCtD
Irbesartan—Oedema peripheral—Timolol—glaucoma	0.000167	0.000517	CcSEcCtD
Irbesartan—Anaemia—Betaxolol—glaucoma	0.000167	0.000517	CcSEcCtD
Irbesartan—Shock—Clonidine—glaucoma	0.000166	0.000516	CcSEcCtD
Irbesartan—Connective tissue disorder—Timolol—glaucoma	0.000166	0.000516	CcSEcCtD
Irbesartan—Pruritus—Brimonidine—glaucoma	0.000166	0.000515	CcSEcCtD
Irbesartan—Headache—Bimatoprost—glaucoma	0.000166	0.000515	CcSEcCtD
Irbesartan—Nervous system disorder—Clonidine—glaucoma	0.000166	0.000514	CcSEcCtD
Irbesartan—Thrombocytopenia—Clonidine—glaucoma	0.000165	0.000514	CcSEcCtD
Irbesartan—Hypersensitivity—Dorzolamide—glaucoma	0.000165	0.000512	CcSEcCtD
Irbesartan—Tachycardia—Clonidine—glaucoma	0.000165	0.000512	CcSEcCtD
Irbesartan—Hypersensitivity—Travoprost—glaucoma	0.000164	0.00051	CcSEcCtD
Irbesartan—Skin disorder—Clonidine—glaucoma	0.000164	0.00051	CcSEcCtD
Irbesartan—Hyperhidrosis—Clonidine—glaucoma	0.000163	0.000507	CcSEcCtD
Irbesartan—Visual impairment—Timolol—glaucoma	0.000163	0.000506	CcSEcCtD
Irbesartan—Malaise—Betaxolol—glaucoma	0.000163	0.000505	CcSEcCtD
Irbesartan—Nausea—Apraclonidine—glaucoma	0.000162	0.000504	CcSEcCtD
Irbesartan—Hypersensitivity—Brinzolamide—glaucoma	0.000162	0.000504	CcSEcCtD
Irbesartan—Vertigo—Betaxolol—glaucoma	0.000162	0.000503	CcSEcCtD
Irbesartan—Syncope—Betaxolol—glaucoma	0.000162	0.000502	CcSEcCtD
Irbesartan—Dizziness—Acetazolamide—glaucoma	0.000162	0.000502	CcSEcCtD
Irbesartan—Anorexia—Clonidine—glaucoma	0.000161	0.0005	CcSEcCtD
Irbesartan—Asthenia—Dorzolamide—glaucoma	0.000161	0.000499	CcSEcCtD
Irbesartan—Asthenia—Travoprost—glaucoma	0.00016	0.000497	CcSEcCtD
Irbesartan—Pruritus—Dorzolamide—glaucoma	0.000158	0.000492	CcSEcCtD
Irbesartan—Loss of consciousness—Betaxolol—glaucoma	0.000158	0.000492	CcSEcCtD
Irbesartan—Asthenia—Brinzolamide—glaucoma	0.000158	0.00049	CcSEcCtD
Irbesartan—Hypotension—Clonidine—glaucoma	0.000158	0.00049	CcSEcCtD
Irbesartan—Pruritus—Travoprost—glaucoma	0.000158	0.00049	CcSEcCtD
Irbesartan—Tinnitus—Timolol—glaucoma	0.000158	0.00049	CcSEcCtD
Irbesartan—Cough—Betaxolol—glaucoma	0.000157	0.000488	CcSEcCtD
Irbesartan—Nausea—Bimatoprost—glaucoma	0.000157	0.000488	CcSEcCtD
Irbesartan—Cardiac disorder—Timolol—glaucoma	0.000157	0.000487	CcSEcCtD
Irbesartan—Hypersensitivity—Pilocarpine—glaucoma	0.000156	0.000484	CcSEcCtD
Irbesartan—Pruritus—Brinzolamide—glaucoma	0.000156	0.000484	CcSEcCtD
Irbesartan—Vomiting—Acetazolamide—glaucoma	0.000155	0.000482	CcSEcCtD
Irbesartan—Dizziness—Brimonidine—glaucoma	0.000155	0.000481	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000154	0.000478	CcSEcCtD
Irbesartan—Angiopathy—Timolol—glaucoma	0.000153	0.000476	CcSEcCtD
Irbesartan—Chest pain—Betaxolol—glaucoma	0.000153	0.000476	CcSEcCtD
Irbesartan—Arthralgia—Betaxolol—glaucoma	0.000153	0.000476	CcSEcCtD
Irbesartan—Myalgia—Betaxolol—glaucoma	0.000153	0.000476	CcSEcCtD
Irbesartan—Diarrhoea—Dorzolamide—glaucoma	0.000153	0.000476	CcSEcCtD
Irbesartan—Headache—Acetazolamide—glaucoma	0.000153	0.000475	CcSEcCtD
Irbesartan—Anxiety—Betaxolol—glaucoma	0.000153	0.000475	CcSEcCtD
Irbesartan—Immune system disorder—Timolol—glaucoma	0.000153	0.000474	CcSEcCtD
Irbesartan—Diarrhoea—Travoprost—glaucoma	0.000153	0.000474	CcSEcCtD
Irbesartan—Mediastinal disorder—Timolol—glaucoma	0.000152	0.000473	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000152	0.000473	CcSEcCtD
Irbesartan—Asthenia—Pilocarpine—glaucoma	0.000152	0.000471	CcSEcCtD
Irbesartan—Paraesthesia—Clonidine—glaucoma	0.000152	0.000471	CcSEcCtD
Irbesartan—Discomfort—Betaxolol—glaucoma	0.000152	0.000471	CcSEcCtD
Irbesartan—Arrhythmia—Timolol—glaucoma	0.000151	0.000469	CcSEcCtD
Irbesartan—Dyspnoea—Clonidine—glaucoma	0.000151	0.000468	CcSEcCtD
Irbesartan—Diarrhoea—Brinzolamide—glaucoma	0.000151	0.000468	CcSEcCtD
Irbesartan—Somnolence—Clonidine—glaucoma	0.00015	0.000466	CcSEcCtD
Irbesartan—Dry mouth—Betaxolol—glaucoma	0.00015	0.000466	CcSEcCtD
Irbesartan—Pruritus—Pilocarpine—glaucoma	0.00015	0.000465	CcSEcCtD
Irbesartan—Dizziness—Dorzolamide—glaucoma	0.000148	0.00046	CcSEcCtD
Irbesartan—Rash—Brimonidine—glaucoma	0.000148	0.000459	CcSEcCtD
Irbesartan—Dermatitis—Brimonidine—glaucoma	0.000148	0.000459	CcSEcCtD
Irbesartan—Dizziness—Travoprost—glaucoma	0.000147	0.000458	CcSEcCtD
Irbesartan—Erythema—Timolol—glaucoma	0.000147	0.000457	CcSEcCtD
Irbesartan—Malnutrition—Timolol—glaucoma	0.000147	0.000457	CcSEcCtD
Irbesartan—Oedema—Betaxolol—glaucoma	0.000147	0.000457	CcSEcCtD
Irbesartan—Headache—Brimonidine—glaucoma	0.000147	0.000456	CcSEcCtD
Irbesartan—Decreased appetite—Clonidine—glaucoma	0.000147	0.000456	CcSEcCtD
Irbesartan—Infection—Betaxolol—glaucoma	0.000146	0.000454	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Clonidine—glaucoma	0.000146	0.000453	CcSEcCtD
Irbesartan—Fatigue—Clonidine—glaucoma	0.000146	0.000452	CcSEcCtD
Irbesartan—Dizziness—Brinzolamide—glaucoma	0.000146	0.000452	CcSEcCtD
Irbesartan—Nausea—Acetazolamide—glaucoma	0.000145	0.000451	CcSEcCtD
Irbesartan—Diarrhoea—Pilocarpine—glaucoma	0.000145	0.000449	CcSEcCtD
Irbesartan—Shock—Betaxolol—glaucoma	0.000145	0.000449	CcSEcCtD
Irbesartan—Tension—Timolol—glaucoma	0.000145	0.000449	CcSEcCtD
Irbesartan—Constipation—Clonidine—glaucoma	0.000145	0.000449	CcSEcCtD
Irbesartan—Pain—Clonidine—glaucoma	0.000145	0.000449	CcSEcCtD
Irbesartan—Nervous system disorder—Betaxolol—glaucoma	0.000144	0.000448	CcSEcCtD
Irbesartan—Dysgeusia—Timolol—glaucoma	0.000144	0.000448	CcSEcCtD
Irbesartan—Thrombocytopenia—Betaxolol—glaucoma	0.000144	0.000447	CcSEcCtD
Irbesartan—Tachycardia—Betaxolol—glaucoma	0.000144	0.000446	CcSEcCtD
Irbesartan—Nervousness—Timolol—glaucoma	0.000143	0.000444	CcSEcCtD
Irbesartan—Skin disorder—Betaxolol—glaucoma	0.000143	0.000444	CcSEcCtD
Irbesartan—Vomiting—Dorzolamide—glaucoma	0.000142	0.000442	CcSEcCtD
Irbesartan—Hyperhidrosis—Betaxolol—glaucoma	0.000142	0.000442	CcSEcCtD
Irbesartan—Rash—Dorzolamide—glaucoma	0.000141	0.000438	CcSEcCtD
Irbesartan—Dermatitis—Dorzolamide—glaucoma	0.000141	0.000438	CcSEcCtD
Irbesartan—Rash—Travoprost—glaucoma	0.000141	0.000436	CcSEcCtD
Irbesartan—Dermatitis—Travoprost—glaucoma	0.00014	0.000436	CcSEcCtD
Irbesartan—Headache—Dorzolamide—glaucoma	0.00014	0.000436	CcSEcCtD
Irbesartan—Anorexia—Betaxolol—glaucoma	0.00014	0.000435	CcSEcCtD
Irbesartan—Vomiting—Brinzolamide—glaucoma	0.00014	0.000435	CcSEcCtD
Irbesartan—Dizziness—Pilocarpine—glaucoma	0.00014	0.000434	CcSEcCtD
Irbesartan—Headache—Travoprost—glaucoma	0.00014	0.000434	CcSEcCtD
Irbesartan—Nausea—Brimonidine—glaucoma	0.000139	0.000432	CcSEcCtD
Irbesartan—Feeling abnormal—Clonidine—glaucoma	0.000139	0.000432	CcSEcCtD
Irbesartan—Rash—Brinzolamide—glaucoma	0.000139	0.000431	CcSEcCtD
Irbesartan—Vision blurred—Timolol—glaucoma	0.000139	0.000431	CcSEcCtD
Irbesartan—Dermatitis—Brinzolamide—glaucoma	0.000139	0.000431	CcSEcCtD
Irbesartan—Gastrointestinal pain—Clonidine—glaucoma	0.000138	0.000429	CcSEcCtD
Irbesartan—Headache—Brinzolamide—glaucoma	0.000138	0.000428	CcSEcCtD
Irbesartan—Hypotension—Betaxolol—glaucoma	0.000137	0.000427	CcSEcCtD
Irbesartan—Angioedema—Timolol—glaucoma	0.000135	0.000418	CcSEcCtD
Irbesartan—Vomiting—Pilocarpine—glaucoma	0.000135	0.000418	CcSEcCtD
Irbesartan—Urticaria—Clonidine—glaucoma	0.000134	0.000417	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000134	0.000416	CcSEcCtD
Irbesartan—Abdominal pain—Clonidine—glaucoma	0.000134	0.000415	CcSEcCtD
Irbesartan—Body temperature increased—Clonidine—glaucoma	0.000134	0.000415	CcSEcCtD
Irbesartan—Rash—Pilocarpine—glaucoma	0.000133	0.000414	CcSEcCtD
Irbesartan—Dermatitis—Pilocarpine—glaucoma	0.000133	0.000414	CcSEcCtD
Irbesartan—Nausea—Dorzolamide—glaucoma	0.000133	0.000413	CcSEcCtD
Irbesartan—Headache—Pilocarpine—glaucoma	0.000133	0.000412	CcSEcCtD
Irbesartan—Nausea—Travoprost—glaucoma	0.000132	0.000411	CcSEcCtD
Irbesartan—Vertigo—Timolol—glaucoma	0.000132	0.000411	CcSEcCtD
Irbesartan—Paraesthesia—Betaxolol—glaucoma	0.000132	0.00041	CcSEcCtD
Irbesartan—Syncope—Timolol—glaucoma	0.000132	0.00041	CcSEcCtD
Irbesartan—Dyspnoea—Betaxolol—glaucoma	0.000131	0.000407	CcSEcCtD
Irbesartan—Nausea—Brinzolamide—glaucoma	0.000131	0.000406	CcSEcCtD
Irbesartan—Dyspepsia—Betaxolol—glaucoma	0.00013	0.000402	CcSEcCtD
Irbesartan—Loss of consciousness—Timolol—glaucoma	0.000129	0.000402	CcSEcCtD
Irbesartan—Cough—Timolol—glaucoma	0.000129	0.000399	CcSEcCtD
Irbesartan—Decreased appetite—Betaxolol—glaucoma	0.000128	0.000397	CcSEcCtD
Irbesartan—Hypertension—Timolol—glaucoma	0.000127	0.000395	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000127	0.000394	CcSEcCtD
Irbesartan—Fatigue—Betaxolol—glaucoma	0.000127	0.000394	CcSEcCtD
Irbesartan—Constipation—Betaxolol—glaucoma	0.000126	0.000391	CcSEcCtD
Irbesartan—Pain—Betaxolol—glaucoma	0.000126	0.000391	CcSEcCtD
Irbesartan—Nausea—Pilocarpine—glaucoma	0.000126	0.00039	CcSEcCtD
Irbesartan—Myalgia—Timolol—glaucoma	0.000125	0.000389	CcSEcCtD
Irbesartan—Chest pain—Timolol—glaucoma	0.000125	0.000389	CcSEcCtD
Irbesartan—Arthralgia—Timolol—glaucoma	0.000125	0.000389	CcSEcCtD
Irbesartan—Anxiety—Timolol—glaucoma	0.000125	0.000388	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000125	0.000387	CcSEcCtD
Irbesartan—Hypersensitivity—Clonidine—glaucoma	0.000125	0.000386	CcSEcCtD
Irbesartan—Discomfort—Timolol—glaucoma	0.000124	0.000385	CcSEcCtD
Irbesartan—Dry mouth—Timolol—glaucoma	0.000123	0.000381	CcSEcCtD
Irbesartan—Asthenia—Clonidine—glaucoma	0.000121	0.000376	CcSEcCtD
Irbesartan—Feeling abnormal—Betaxolol—glaucoma	0.000121	0.000376	CcSEcCtD
Irbesartan—Oedema—Timolol—glaucoma	0.00012	0.000373	CcSEcCtD
Irbesartan—Anaphylactic shock—Timolol—glaucoma	0.00012	0.000373	CcSEcCtD
Irbesartan—Pruritus—Clonidine—glaucoma	0.00012	0.000371	CcSEcCtD
Irbesartan—Infection—Timolol—glaucoma	0.000119	0.000371	CcSEcCtD
Irbesartan—Shock—Timolol—glaucoma	0.000118	0.000367	CcSEcCtD
Irbesartan—Nervous system disorder—Timolol—glaucoma	0.000118	0.000366	CcSEcCtD
Irbesartan—Urticaria—Betaxolol—glaucoma	0.000117	0.000363	CcSEcCtD
Irbesartan—Skin disorder—Timolol—glaucoma	0.000117	0.000362	CcSEcCtD
Irbesartan—Body temperature increased—Betaxolol—glaucoma	0.000116	0.000361	CcSEcCtD
Irbesartan—Hyperhidrosis—Timolol—glaucoma	0.000116	0.000361	CcSEcCtD
Irbesartan—Diarrhoea—Clonidine—glaucoma	0.000116	0.000359	CcSEcCtD
Irbesartan—Anorexia—Timolol—glaucoma	0.000115	0.000356	CcSEcCtD
Irbesartan—Hypotension—Timolol—glaucoma	0.000112	0.000349	CcSEcCtD
Irbesartan—Dizziness—Clonidine—glaucoma	0.000112	0.000347	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Timolol—glaucoma	0.00011	0.00034	CcSEcCtD
Irbesartan—Hypersensitivity—Betaxolol—glaucoma	0.000108	0.000336	CcSEcCtD
Irbesartan—Paraesthesia—Timolol—glaucoma	0.000108	0.000335	CcSEcCtD
Irbesartan—Vomiting—Clonidine—glaucoma	0.000107	0.000334	CcSEcCtD
Irbesartan—Dyspnoea—Timolol—glaucoma	0.000107	0.000333	CcSEcCtD
Irbesartan—Somnolence—Timolol—glaucoma	0.000107	0.000332	CcSEcCtD
Irbesartan—Rash—Clonidine—glaucoma	0.000107	0.000331	CcSEcCtD
Irbesartan—Dermatitis—Clonidine—glaucoma	0.000106	0.00033	CcSEcCtD
Irbesartan—Headache—Clonidine—glaucoma	0.000106	0.000329	CcSEcCtD
Irbesartan—Dyspepsia—Timolol—glaucoma	0.000106	0.000328	CcSEcCtD
Irbesartan—Asthenia—Betaxolol—glaucoma	0.000106	0.000328	CcSEcCtD
Irbesartan—Decreased appetite—Timolol—glaucoma	0.000104	0.000324	CcSEcCtD
Irbesartan—Pruritus—Betaxolol—glaucoma	0.000104	0.000323	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Timolol—glaucoma	0.000104	0.000322	CcSEcCtD
Irbesartan—Fatigue—Timolol—glaucoma	0.000104	0.000322	CcSEcCtD
Irbesartan—Pain—Timolol—glaucoma	0.000103	0.000319	CcSEcCtD
Irbesartan—Diarrhoea—Betaxolol—glaucoma	0.000101	0.000312	CcSEcCtD
Irbesartan—Nausea—Clonidine—glaucoma	0.0001	0.000312	CcSEcCtD
Irbesartan—Feeling abnormal—Timolol—glaucoma	9.9e-05	0.000307	CcSEcCtD
Irbesartan—Gastrointestinal pain—Timolol—glaucoma	9.83e-05	0.000305	CcSEcCtD
Irbesartan—Dizziness—Betaxolol—glaucoma	9.73e-05	0.000302	CcSEcCtD
Irbesartan—Urticaria—Timolol—glaucoma	9.55e-05	0.000296	CcSEcCtD
Irbesartan—Body temperature increased—Timolol—glaucoma	9.5e-05	0.000295	CcSEcCtD
Irbesartan—Abdominal pain—Timolol—glaucoma	9.5e-05	0.000295	CcSEcCtD
Irbesartan—Vomiting—Betaxolol—glaucoma	9.35e-05	0.00029	CcSEcCtD
Irbesartan—Rash—Betaxolol—glaucoma	9.28e-05	0.000288	CcSEcCtD
Irbesartan—Dermatitis—Betaxolol—glaucoma	9.27e-05	0.000288	CcSEcCtD
Irbesartan—Headache—Betaxolol—glaucoma	9.22e-05	0.000286	CcSEcCtD
Irbesartan—Hypersensitivity—Timolol—glaucoma	8.86e-05	0.000275	CcSEcCtD
Irbesartan—Nausea—Betaxolol—glaucoma	8.74e-05	0.000271	CcSEcCtD
Irbesartan—Asthenia—Timolol—glaucoma	8.62e-05	0.000268	CcSEcCtD
Irbesartan—Pruritus—Timolol—glaucoma	8.5e-05	0.000264	CcSEcCtD
Irbesartan—Diarrhoea—Timolol—glaucoma	8.22e-05	0.000255	CcSEcCtD
Irbesartan—Dizziness—Timolol—glaucoma	7.95e-05	0.000247	CcSEcCtD
Irbesartan—Vomiting—Timolol—glaucoma	7.64e-05	0.000237	CcSEcCtD
Irbesartan—Rash—Timolol—glaucoma	7.58e-05	0.000235	CcSEcCtD
Irbesartan—Dermatitis—Timolol—glaucoma	7.57e-05	0.000235	CcSEcCtD
Irbesartan—Headache—Timolol—glaucoma	7.53e-05	0.000234	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—SMO—glaucoma	7.45e-05	0.00047	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NARFL—glaucoma	7.44e-05	0.000469	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CA5A—glaucoma	7.44e-05	0.000469	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—VEGFA—glaucoma	7.39e-05	0.000466	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GSTT1—glaucoma	7.38e-05	0.000465	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.36e-05	0.000464	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TP53—glaucoma	7.24e-05	0.000457	CbGpPWpGaD
Irbesartan—JUN—Signaling by NOTCH—TP53—glaucoma	7.24e-05	0.000457	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—OPN4—glaucoma	7.24e-05	0.000457	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	7.21e-05	0.000454	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.21e-05	0.000454	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.2e-05	0.000454	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—HDAC9—glaucoma	7.17e-05	0.000452	CbGpPWpGaD
Irbesartan—Nausea—Timolol—glaucoma	7.14e-05	0.000222	CcSEcCtD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	7.12e-05	0.000449	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—CYP1B1—glaucoma	6.94e-05	0.000437	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—EDN1—glaucoma	6.89e-05	0.000435	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—CYP1B1—glaucoma	6.88e-05	0.000434	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	6.84e-05	0.000431	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—RPTOR—glaucoma	6.83e-05	0.000431	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	6.81e-05	0.000429	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	6.79e-05	0.000428	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	6.76e-05	0.000426	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GSTM1—glaucoma	6.76e-05	0.000426	CbGpPWpGaD
Irbesartan—JUN—Oxidative Stress Induced Senescence—TP53—glaucoma	6.75e-05	0.000426	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HEYL—glaucoma	6.73e-05	0.000424	CbGpPWpGaD
Irbesartan—JUN—Immune System—TXN—glaucoma	6.71e-05	0.000423	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	6.67e-05	0.00042	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NCK2—glaucoma	6.62e-05	0.000417	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PTGFR—glaucoma	6.52e-05	0.000411	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—TXN—glaucoma	6.43e-05	0.000405	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.43e-05	0.000405	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN2A—glaucoma	6.41e-05	0.000404	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—EDN1—glaucoma	6.26e-05	0.000395	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TP53—glaucoma	6.22e-05	0.000392	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—glaucoma	6.17e-05	0.000389	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—VEGFA—glaucoma	6.15e-05	0.000387	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.12e-05	0.000386	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NARFL—glaucoma	6.1e-05	0.000385	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CA5A—glaucoma	6.1e-05	0.000385	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NARFL—glaucoma	6.05e-05	0.000381	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CA5A—glaucoma	6.05e-05	0.000381	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—C3—glaucoma	6.02e-05	0.00038	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	6e-05	0.000378	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—TP53—glaucoma	5.93e-05	0.000374	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—CYP1B1—glaucoma	5.88e-05	0.000371	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—glaucoma	5.81e-05	0.000366	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	5.8e-05	0.000365	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.69e-05	0.000359	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CDKN1B—glaucoma	5.68e-05	0.000358	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—HDAC9—glaucoma	5.63e-05	0.000355	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CA1—glaucoma	5.62e-05	0.000354	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SMO—glaucoma	5.61e-05	0.000354	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—TP53—glaucoma	5.58e-05	0.000352	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GSTM1—glaucoma	5.55e-05	0.00035	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GSTM1—glaucoma	5.5e-05	0.000347	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.49e-05	0.000346	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	5.47e-05	0.000345	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—C3—glaucoma	5.47e-05	0.000345	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CTSA—glaucoma	5.44e-05	0.000343	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	5.42e-05	0.000342	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—EDN1—glaucoma	5.41e-05	0.000341	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.25e-05	0.000331	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CA5A—glaucoma	5.17e-05	0.000326	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NARFL—glaucoma	5.17e-05	0.000326	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CA2—glaucoma	5.14e-05	0.000324	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.14e-05	0.000324	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5.14e-05	0.000324	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NTRK2—glaucoma	5.13e-05	0.000323	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TP53—glaucoma	5.12e-05	0.000323	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—RPTOR—glaucoma	5.1e-05	0.000322	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—C3—glaucoma	5.03e-05	0.000317	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.03e-05	0.000317	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.03e-05	0.000317	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTT1—glaucoma	4.99e-05	0.000314	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NCK2—glaucoma	4.94e-05	0.000312	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—EDN1—glaucoma	4.91e-05	0.00031	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—BCL2L1—glaucoma	4.82e-05	0.000303	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—C3—glaucoma	4.73e-05	0.000298	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—VEGFA—glaucoma	4.72e-05	0.000298	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—TP53—glaucoma	4.72e-05	0.000298	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GSTM1—glaucoma	4.7e-05	0.000296	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	4.64e-05	0.000292	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.62e-05	0.000291	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.54e-05	0.000286	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.48e-05	0.000282	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—TP53—glaucoma	4.44e-05	0.00028	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NGFR—glaucoma	4.4e-05	0.000277	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SMO—glaucoma	4.4e-05	0.000277	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—BAD—glaucoma	4.36e-05	0.000275	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—C3—glaucoma	4.29e-05	0.000271	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—HDAC9—glaucoma	4.2e-05	0.000265	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NTRK1—glaucoma	4.18e-05	0.000264	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NTRK2—glaucoma	4.03e-05	0.000254	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA5A—glaucoma	3.99e-05	0.000252	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NARFL—glaucoma	3.99e-05	0.000252	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CYP1B1—glaucoma	3.97e-05	0.00025	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—ABCA1—glaucoma	3.97e-05	0.00025	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN2B—glaucoma	3.85e-05	0.000243	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—EDN1—glaucoma	3.7e-05	0.000233	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CA1—glaucoma	3.63e-05	0.000229	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.63e-05	0.000229	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—TXN—glaucoma	3.62e-05	0.000228	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.58e-05	0.000225	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—TP53—glaucoma	3.57e-05	0.000225	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CTSA—glaucoma	3.52e-05	0.000222	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NGFR—glaucoma	3.45e-05	0.000218	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NGF—glaucoma	3.4e-05	0.000214	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1A—glaucoma	3.33e-05	0.00021	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CA2—glaucoma	3.32e-05	0.000209	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.31e-05	0.000208	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SMO—glaucoma	3.29e-05	0.000207	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NTRK1—glaucoma	3.28e-05	0.000207	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.28e-05	0.000206	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.25e-05	0.000205	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.25e-05	0.000205	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—C3—glaucoma	3.23e-05	0.000204	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTM1—glaucoma	3.18e-05	0.0002	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CDKN1B—glaucoma	3.04e-05	0.000192	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN2B—glaucoma	3.02e-05	0.000191	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—APOE—glaucoma	3.01e-05	0.00019	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NTRK2—glaucoma	3.01e-05	0.00019	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CA1—glaucoma	2.98e-05	0.000188	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CAV1—glaucoma	2.98e-05	0.000188	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CA1—glaucoma	2.96e-05	0.000186	CbGpPWpGaD
Irbesartan—JUN—Immune System—C3—glaucoma	2.93e-05	0.000185	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—EDN1—glaucoma	2.9e-05	0.000183	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CTSA—glaucoma	2.89e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CTSA—glaucoma	2.86e-05	0.00018	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FN1—glaucoma	2.84e-05	0.000179	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTT1—glaucoma	2.81e-05	0.000177	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—MTHFR—glaucoma	2.81e-05	0.000177	CbGpPWpGaD
Irbesartan—JUN—Immune System—BCL2L1—glaucoma	2.8e-05	0.000177	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—BAD—glaucoma	2.8e-05	0.000177	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CA2—glaucoma	2.73e-05	0.000172	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CA2—glaucoma	2.7e-05	0.00017	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NGF—glaucoma	2.67e-05	0.000168	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.64e-05	0.000167	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.64e-05	0.000167	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—APOE—glaucoma	2.61e-05	0.000165	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CAV1—glaucoma	2.59e-05	0.000163	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NGFR—glaucoma	2.58e-05	0.000163	CbGpPWpGaD
Irbesartan—JUN—Immune System—BAD—glaucoma	2.54e-05	0.00016	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—C3—glaucoma	2.54e-05	0.00016	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CA1—glaucoma	2.53e-05	0.000159	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NTRK1—glaucoma	2.45e-05	0.000155	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CTSA—glaucoma	2.45e-05	0.000154	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—APOE—glaucoma	2.36e-05	0.000149	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—TXN—glaucoma	2.34e-05	0.000147	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CAV1—glaucoma	2.34e-05	0.000147	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CA2—glaucoma	2.31e-05	0.000146	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.27e-05	0.000143	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN2B—glaucoma	2.26e-05	0.000142	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.26e-05	0.000142	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.26e-05	0.000142	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NOS3—glaucoma	2.25e-05	0.000142	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CYP1B1—glaucoma	2.24e-05	0.000141	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ABCA1—glaucoma	2.24e-05	0.000141	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FN1—glaucoma	2.23e-05	0.00014	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—BAD—glaucoma	2.2e-05	0.000139	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—EDN1—glaucoma	2.17e-05	0.000137	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.14e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.12e-05	0.000133	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NGF—glaucoma	1.99e-05	0.000126	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—NOS3—glaucoma	1.96e-05	0.000123	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CDKN1B—glaucoma	1.95e-05	0.000123	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA1—glaucoma	1.95e-05	0.000123	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—TXN—glaucoma	1.92e-05	0.000121	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—TXN—glaucoma	1.9e-05	0.00012	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—C3—glaucoma	1.89e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CTSA—glaucoma	1.89e-05	0.000119	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTT1—glaucoma	1.81e-05	0.000114	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—glaucoma	1.81e-05	0.000114	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—glaucoma	1.79e-05	0.000113	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTM1—glaucoma	1.79e-05	0.000113	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CA2—glaucoma	1.78e-05	0.000112	CbGpPWpGaD
Irbesartan—JUN—Immune System—CDKN1B—glaucoma	1.77e-05	0.000112	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NOS3—glaucoma	1.77e-05	0.000111	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—APOE—glaucoma	1.76e-05	0.000111	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CAV1—glaucoma	1.75e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.74e-05	0.00011	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.72e-05	0.000109	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FN1—glaucoma	1.66e-05	0.000105	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—BAD—glaucoma	1.64e-05	0.000104	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—TXN—glaucoma	1.63e-05	0.000103	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—VEGFA—glaucoma	1.62e-05	0.000102	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—MTHFR—glaucoma	1.58e-05	9.97e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CDKN1B—glaucoma	1.53e-05	9.65e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTT1—glaucoma	1.49e-05	9.39e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.49e-05	9.36e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTT1—glaucoma	1.48e-05	9.31e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—APOE—glaucoma	1.47e-05	9.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.47e-05	9.27e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.46e-05	9.22e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CAV1—glaucoma	1.46e-05	9.19e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ABCA1—glaucoma	1.45e-05	9.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CYP1B1—glaucoma	1.45e-05	9.11e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—glaucoma	1.42e-05	8.94e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NOS3—glaucoma	1.32e-05	8.33e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—VEGFA—glaucoma	1.27e-05	8.03e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTT1—glaucoma	1.26e-05	7.95e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—TXN—glaucoma	1.26e-05	7.92e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TP53—glaucoma	1.23e-05	7.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.19e-05	7.51e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP1B1—glaucoma	1.19e-05	7.48e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ABCA1—glaucoma	1.19e-05	7.48e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ABCA1—glaucoma	1.18e-05	7.42e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP1B1—glaucoma	1.18e-05	7.42e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTM1—glaucoma	1.16e-05	7.28e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CDKN1B—glaucoma	1.14e-05	7.21e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—glaucoma	1.1e-05	6.95e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—glaucoma	1.06e-05	6.68e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—glaucoma	1.02e-05	6.44e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.02e-05	6.41e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—glaucoma	1.01e-05	6.36e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP1B1—glaucoma	1.01e-05	6.34e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ABCA1—glaucoma	1.01e-05	6.34e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTT1—glaucoma	9.74e-06	6.14e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TP53—glaucoma	9.63e-06	6.07e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—VEGFA—glaucoma	9.52e-06	6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—glaucoma	9.51e-06	5.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTM1—glaucoma	9.49e-06	5.98e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAV1—glaucoma	9.42e-06	5.94e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTM1—glaucoma	9.41e-06	5.93e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—glaucoma	8.39e-06	5.29e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—glaucoma	8.31e-06	5.24e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTM1—glaucoma	8.04e-06	5.07e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—glaucoma	7.81e-06	4.92e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ABCA1—glaucoma	7.76e-06	4.89e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP1B1—glaucoma	7.76e-06	4.89e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—glaucoma	7.74e-06	4.88e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAV1—glaucoma	7.73e-06	4.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAV1—glaucoma	7.67e-06	4.83e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TP53—glaucoma	7.19e-06	4.53e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—glaucoma	7.12e-06	4.49e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—glaucoma	7.1e-06	4.48e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—glaucoma	6.61e-06	4.17e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAV1—glaucoma	6.55e-06	4.13e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—glaucoma	6.52e-06	4.11e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTM1—glaucoma	6.2e-06	3.91e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—glaucoma	5.85e-06	3.69e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—glaucoma	5.8e-06	3.65e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—glaucoma	5.48e-06	3.46e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—glaucoma	5.35e-06	3.37e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—glaucoma	5.3e-06	3.34e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—glaucoma	5.1e-06	3.22e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAV1—glaucoma	5.06e-06	3.19e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—glaucoma	4.95e-06	3.12e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—glaucoma	4.53e-06	2.86e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—glaucoma	3.82e-06	2.41e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—glaucoma	3.5e-06	2.2e-05	CbGpPWpGaD
